Skip to main content

Advertisement

Log in

S100A10 as a novel biomarker in colorectal cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Recent data support the role of S100A10 in tumorigenesis. In this study, we evaluated the value of S100A10 positivity as a possible biomarker in colorectal cancer. We evaluated S100A10 positivity by immunohistochemistry in a large population of colorectal cancer patients (n = 882). The relationships between S100A10 positivity and clinicopathological features and clinical outcome were analyzed. There were 36 % (319/882) tumors positive for S100A10 in all colorectal cancer samples. In contrast, normal colorectal epithelium was negative for S100A10 among all 562 specimens of adjacent normal mucosa. S100A10 positivity was correlated with poor differentiation (p = 0.0012) and disease stage (p = 0.003). S100A10 positivity was significantly correlated with shortened specific [log-rank p < 0.001; multivariate hazard ratio (HR), 1.49; 95 % confidence interval (CI), 1.09–2.04] and overall survival (log-rank p = 0.0012; multivariate HR, 1.34; 95 % CI, 1.06–1.73). Knockdown of S100A10 by siRNA significantly reduced the proliferation, migration, and invasion capacity of colorectal cancer cell lines. Our results suggest a role for S100A10 as a prognostic marker and potential therapeutic target in colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech. 2003;60:540–51.

    Article  PubMed  CAS  Google Scholar 

  2. Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the S100 proteins in cancer. Eur J Surg Oncol. 2008;34:357–64.

    Article  PubMed  CAS  Google Scholar 

  3. Kwon M, Caplan JF, Filipenko NR, et al. Identification of annexin II heterotetramer as a plasmin reductase. J Biol Chem. 2002;2156:10903–11.

    Article  Google Scholar 

  4. Hildenbrand R, Allgayer H, Marx A, Stroebel P. Modulators of the urokinase-type plasminogen activation system for cancer. Expert Opin Investig Drugs. 2010;19:641–52.

    Article  PubMed  CAS  Google Scholar 

  5. Ito Y, Arai K, Nozawa R, et al. S100A10 positivity in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma. Anticancer Res. 2007;27:2679–83.

    PubMed  CAS  Google Scholar 

  6. McKiernan E, McDermott EW, Evoy D, Crown J, Duffy MJ. The role of S100 genes in breast cancer progression. Tumor Biol. 2011;32:441–50.

    Article  CAS  Google Scholar 

  7. Teratani T, Watanabe T, Kuwahara F, et al. Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes in human renal cell carcinoma. Cancer Lett. 2002;175:71–7.

    Article  PubMed  CAS  Google Scholar 

  8. El-Rifai W, Moskaluk CA, Abdrabbo MK, et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 2002;62:6823–6.

    PubMed  CAS  Google Scholar 

  9. Morikawa T, Kuchiba A, Qian ZR, Mino-Kenudson M, Hornick JL, Yamauchi M, et al. Prognostic significance and molecular relationships of tumor growth pattern in colorectal cancer. Ann Surg Oncol. 2012;19:1944–53.

    Article  PubMed  Google Scholar 

  10. Giovannucci E, Fuchs CS, Ogino S. Relationship of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA. 2011;305:1685–94.

    Article  PubMed  Google Scholar 

  11. Choi KS, Fogg DK, Yoon CS, Waisman DM. p11 regulates extracellular plasmin production and invasiveness of HT1080 fibrosarcoma cells. FASEB J. 2003;17:235–46.

    Article  PubMed  CAS  Google Scholar 

  12. Madureira PA, O’Connell PA, Surette AP, Miller VA, Waisman DM. The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis. J Biomed Biotechnol. 2012;2012:353687.

    PubMed  Google Scholar 

  13. Zhang L, Fogg DK, Waisman DM. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem. 2004;279:2053–62.

    Article  PubMed  CAS  Google Scholar 

  14. Domoto T, Miyama Y, Suzuki H, Teratani T, Arai K, Sugiyama T, et al. Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci. 2007;98:77–82.

    Article  PubMed  CAS  Google Scholar 

  15. Tan Y, Ma SY, Wang FQ, Meng HP, Mei C, Liu A, et al. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer. Oncol Rep. 2011;26:853–9.

    PubMed  CAS  Google Scholar 

  16. Masiakowski P, Shooter EM. Changes in PC12 cell morphology induced by transfection with 42C cDNA, coding for a member of the S-100 protein family. J Neurosci Res. 1990;27:264–9.

    Article  PubMed  CAS  Google Scholar 

  17. Li Q, Laumonnier Y, Syrovets T, Simmet T. Plasmin triggers cytokine induction in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol. 2007;27:1383–9.

    Article  PubMed  Google Scholar 

  18. Becker C, Fantini MC, Schramm C, et al. TGF-beta suppresses tumor progression in colorectal cancer by inhibition of IL-6 trans-signaling. Immunity. 2004;21:491–501.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhanxue Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shang, J., Zhang, Z., Song, W. et al. S100A10 as a novel biomarker in colorectal cancer. Tumor Biol. 34, 3785–3790 (2013). https://doi.org/10.1007/s13277-013-0962-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-0962-1

Keywords

Navigation